MOVE vs MNMD vs LWAY vs HIMS

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus 13. 7% for Lifeway Foods, Inc. (LWAY). Lifeway Foods, Inc. (LWAY) offers the better valuation at 28. 8x trailing P/E (20. 7x forward), making it the more compelling value choice. Analysts rate Movano Inc. (MOVE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Lifeway Foods, Inc.

(LWAY) is the cheapest at 28. 8x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Lifeway Foods, Inc. is actually cheaper at 20. 7x.

Over the past 5 years, Lifeway Foods, Inc.

(LWAY) delivered a total return of +427. 0%, compared to -98. 2% for Movano Inc. (MOVE). Over 10 years, the gap is even starker: MNMD returned +512. 1% versus MOVE's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Lifeway Foods, Inc.

(LWAY) is the lower-risk stock at 0. 72β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 232% more volatile than LWAY relative to the S&P 500. On balance sheet safety, Lifeway Foods, Inc. (LWAY) carries a lower debt/equity ratio of 0% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus 13. 7% for Lifeway Foods, Inc. (LWAY). On earnings-per-share growth, the picture is similar: Lifeway Foods, Inc. grew EPS 50. 8% year-over-year, compared to -1273. 3% for Mind Medicine (MindMed) Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Lifeway Foods, Inc.

(LWAY) is the more profitable company, earning 6. 5% net margin versus -23. 4% for Movano Inc. — meaning it keeps 6. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LWAY leads at 7. 6% versus -23. 9% for MOVE. At the gross margin level — before operating expenses — HIMS leads at 59. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Lifeway Foods, Inc.

(LWAY) trades at 20. 7x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 30. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LWAY: 36. 5% to $35. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Lifeway Foods, Inc.

(LWAY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72), +167. 1% 10Y return). Movano Inc. (MOVE) carries a higher beta of 1. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LWAY: +167. 1%, MOVE: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MOVE (Healthcare) and MNMD (Healthcare) and LWAY (Consumer Defensive) and HIMS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MOVE is a small-cap quality compounder stock; MNMD is a small-cap quality compounder stock; LWAY is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.